Earnings History Data for Absci Corporation (ABSI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Absci Corporation

Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company's Creation(TM) Platform involved in discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single efficient process. Absci Corporation is based in VANCOUVER, Wash.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-05-2025	AH		ABSI	Absci Corporation	350.17	-0.21	-0.23	-0.22	Absci GAAP EPS of -$0.21 beats by $0.02, revenue of $1.18M beats by $0.11M [5/13/2025 4:12 PM]	2.92	-0.04 (-1.35%)	3.63	0.67 (22.64%)	2.01 - 6.33	9,448,174	2,500,000	628,610
Absci signals expanded clinical pipeline with ABS-101 in Phase I and ABS-201 targeting early 2026 trial [5/13/2025 10:45 PM] Absci GAAP EPS of -$0.21 beats by $0.02, revenue of $1.18M beats by $0.11M [5/13/2025 4:12 PM] What To Expect From Absci Corp (ABSI) Q1 2025 Earnings [May-12-25 09:35AM] Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results [2025-05-13 04:05PM] Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease [2025-05-13 04:01PM] Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates [2025-05-13 05:30PM] Absci Corp (ABSI) Q1 2025 Earnings Call Highlights: Transition to Clinical Stage and Strong ... [2025-05-14 03:17AM] Q1 2025 Absci Corp Earnings Call [2025-05-14 08:32AM]
18-03-2025	AH		ABSI	Absci Corporation	360.65	-0.25	-0.22	-0.25	Absci GAAP EPS of -$0.25 misses by $0.01, revenue of $0.7M misses by $1.07M [3/18/2025 4:10 PM]	2.96	-0.12 (-3.73%)	3.00	-0.08 (-2.60%)	2.45 - 6.72	5,113,341	3,800,000	228,627
Absci GAAP EPS of -$0.25 misses by $0.01, revenue of $0.7M misses by $1.07M [3/18/2025 4:10 PM] Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results [2025-03-18 04:05PM] Absci Corp (ABSI) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... [2025-03-19 03:03AM] Q4 2024 Absci Corp Earnings Call [2025-03-19 09:08AM]
12-11-2024	PM		ABSI	Absci Corporation	462.17	-0.24	-0.19	-0.24	Absci misses Q3 estimates [11/12/2024 7:34 AM]	3.62	-0.66 (-15.30%)	4.10	-0.18 (-4.21%)	1.22 - 6.72	1,995,561	1,220,000	35,877
Absci misses Q3 estimates [11/12/2024 7:34 AM] Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results [2024-11-12 07:30AM] Absci Corp (ABSI) Q3 2024 Earnings Report Preview: What to Look For [Nov-11-24 07:15AM]
14-08-2024	AH		ABSI	Absci Corporation	417.28	-0.22	-0.19	-0.27	Absci GAAP EPS of -$0.22 misses by $0.02, revenue of $1.27M misses by $0.64M [8/14/2024 4:31 PM]	4.12	0.39 (10.32%)	3.73	0.0 (0.00%)	1.11 - 6.72	1,608,396	960,000	65,235
Absci GAAP EPS of -$0.22 misses by $0.02, revenue of $1.27M misses by $0.64M [8/14/2024 4:31 PM]
14-05-2024	PM		ABSI	Absci Corporation	553.77	-0.22	-0.19	-0.26	Absci GAAP EPS of -$0.22 [5/14/2024 7:36 AM]	4.83	-0.23 (-4.56%)	4.75	-0.31 (-6.13%)	1.11 - 6.72	620,531	660,000	15,729
Absci GAAP EPS of -$0.22 [5/14/2024 7:36 AM] Absci Q1 2024 Earnings Preview [5/13/2024 12:14 PM]
21-03-2024	PM		ABSI	Absci Corporation	447.00	-0.25	-0.23	0.00	Absci GAAP EPS of -$0.25 misses by $0.01, revenue of $0.34M misses by $0.69M [3/21/2024 11:27 AM]	5.26	0.17 (3.44%)	5.24	0.15 (2.95%)	1.11 - 6.40	1,438,928	1,230,000	10,455
Absci GAAP EPS of -$0.25 misses by $0.01, revenue of $0.34M misses by $0.69M [3/21/2024 11:27 AM]
14-11-2023	AH		ABSI	Absci Corporation	118.00	-0.24	-0.23	0.00	Absci GAAP EPS of -$0.24, revenue of $0.7M [11/14/2023 5:26 PM]	1.41	0.01 (0.36%)	1.28	-0.12 (-8.57%)	1.11 - 3.63	574,403	420,000	99,081
Absci, Almirall partner on dermatologic drug development [11/14/2023 7:33 AM] Absci GAAP EPS of -$0.24, revenue of $0.7M [11/14/2023 5:26 PM]
14-08-2023	PM		ABSI	Absci Corporation	158.00	-0.27	-0.24	0.00	Absci GAAP EPS of -$0.45 misses by $0.21, revenue of $3.4M beats by $0.96M [8/14/2023 11:12 AM]	1.76	0.08 (4.76%)	0.0	0.0 (0.00%)	1.13 - 4.91	260,943	400,000	0
Absci appoints Zach Jonasson as Chief Financial Officer and Chief Business Officer [8/14/2023 8:40 AM] Absci GAAP EPS of -$0.45 misses by $0.21, revenue of $3.4M beats by $0.96M [8/14/2023 11:12 AM]
15-05-2023	AH	After the close (May 15)	ABSI	Absci Corporation	115.00	-0.26	-0.24	0.00	Absci GAAP EPS of -$0.26, revenue of $1.3M [5/15/2023 5:20 PM]	1.18	-0.10 (-7.81%)	1.31	0.03 (2.34%)	1.14 - 7.04	477,815	400,000	1,525
Absci GAAP EPS of -$0.26, revenue of $1.3M [5/15/2023 5:20 PM]
30-03-2023	PM		ABSI	Absci Corporation	151.00	-0.21	-0.24	0.00	Absci GAAP EPS of -$0.21 beats by $0.04, revenue of $1.56M misses by $2.54M [3/31/2023 12:33 AM]	1.78	0.10 (5.95%)	1.68	0.0 (0.00%)	1.53 - 9.09	211,866	420,000	7,119
Absci GAAP EPS of -$0.21 beats by $0.04, revenue of $1.56M misses by $2.54M [3/31/2023 12:33 AM]
09-11-2022	PM		ABSI	Absci Corporation	274.82	-0.30	-0.27	-0.28	Absci GAAP EPS of -$0.30 misses by $0.02, revenue of $2.37M beats by $0.5M [11/9/2022 8:46 AM]	3.17	0.10 (3.26%)	3.07	0.0 (0.00%)	2.58 - 17.00	163,541	170,000	2,481
Absci GAAP EPS of -$0.30 misses by $0.02, revenue of $2.37M beats by $0.5M [11/9/2022 8:46 AM] Absci Reports Third Quarter 2022 Financial Results [Nov-09-22 08:00AM]
11-08-2022	PM		ABSI	Absci Corporation	362.00	-0.32	-0.32	0.00	Absci GAAP EPS of -$0.32 misses by $0.01, revenue of $1M misses by $0.68M [8/11/2022 9:07 AM]	4.82	0.62 (14.76%)	4.16	-0.04 (-0.95%)	2.93 - 26.79	14,979,670	430,000	1,039
Absci GAAP EPS of -$0.32 misses by $0.01, revenue of $1M misses by $0.68M [8/11/2022 9:07 AM] Absci up as much as 37% after saying it has enough cash to operate through 2025 [8/11/2022 2:11 PM] Absci Reports Second Quarter 2022 Financial Results and Business Update [Aug-11-22 08:00AM] Vancouver biotech firm Absci lays off employees, cites economy [Aug-10-22 10:50AM] The Zacks Analyst Blog Highlights Absci Axcella Health, Freeline Therapeutics Holdings, DICE Therapeutics and Pliant Therapeutics [Aug-10-22 08:19AM]
11-05-2022	PM		ABSI	Absci Corporation	398.00	-0.33	-0.29	0.00	Absci GAAP EPS of -$0.33 misses by $0.04, revenue of $0.82M misses by $1.04M [5/11/2022 8:49 AM]	3.48	-0.52 (-13.00%)	3.71	-0.29 (-7.25%)	3.38 - 31.53	690,956	480,000	4,120
Absci GAAP EPS of -$0.33 misses by $0.04, revenue of $0.82M misses by $1.04M [5/11/2022 8:49 AM] Absci Reports First Quarter 2022 Financial and Operating Results [May-11-22 08:00AM]
09-11-2021	PM	8:30 AM ET (Nov 9)	ABSI	Absci Corporation	1,580	-0.28	-0.21	0.00	Absci EPS misses by $0.14, misses on revenue [11/9/2021 7:27 AM]	14.17	-3.86 (-21.41%)	16.87	-1.16 (-6.43%)	9.62 - 31.53	440,947	170,000	154
Absci EPS misses by $0.14, misses on revenue [11/9/2021 7:27 AM] Absci sinks after quarterly miss as net loss widens [11/9/2021 11:27 AM] Absci Reports Third Quarter 2021 Financial and Operating Results [Nov-09-21 07:00AM]